| Adherence/Uyum....................................................................92 |
| Admitted patients/Kabul edilen hastalar...................................6 |
| Adverse effects/İstenmeyen etkiler.......................................25 |
| ALT/ALT....................................................................................67 |
| Anti-HDV/Anti-HDV..................................................................14 |
| Anxiety/Anksiyete..............................................................25, 92 |
| AST/AST...................................................................................67 |
| Atherosclerosis/Ateroskleroz...................................................35 |
| Awareness/Farkındalık.......................................................6, 101 |
| Bangladesh/Bangladeş..............................................................6 |
| Biopsy/Biyopsi...........................................................................1 |
| Chronic HCV/Kronik HCV........................................................67 |
| Chronic hepatitis B/Kronik hepatit B...................................1, 45 |
| Chronic hepatitis C/Kronik hepatit C.....................................101 |
| Chronic viral hepatitis/Kronik viral hepatit...............................88 |
| Cognitive status/Bilişsel durum..............................................79 |
| Dental Healthcare Center/Diş Sağlığı Merkezi.......................75 |
| Depression/Depresyon......................................................25, 92 |
| Direct acting antiviral agents/Direkt etkili antiviral ilaçlar........25 |
| Direct-acting antiviral agent/Direk etkili antiviral ajan...........105 |
| Direct-acting antivirals/Direkt etkili antiviraller........................55 |
| Epidemiology/Epidemiyoloji....................................................59 |
| Fibrosis/Fibroz..........................................................................67 |
| Fibrosis/Fibrozis........................................................................45 |
| Genotype/Genotip.............................................................59, 62 |
| Haemodialysis/Hemodiyaliz..................................................109 |
| HBV polymerase gene mutation/HBV polimeraz gen mutasyonu.....40 |
| HBV/HBV.................................................................................14 |
| HCV genotypes/HCV genotip.................................................55 |
| HCV-RNA/HCV-RNA................................................................67 |
| HDV infection/HDV enfeksiyonu.............................................97 |
| HDV-RNA/HDV-RNA................................................................14 |
| HDV/HDV.................................................................................97 |
| Hemodialysis/Hemodiyaliz..............................................88, 105 |
| Hepatitis B virus/Hepatit B virüs.............................................50 |
| Hepatitis B virus/Hepatit B virüsü...........................................40 |
| Hepatitis B/Hepatit B.........................................................35, 92 |
| Hepatitis C virus/Hepatit C virüs.....................................59, 109 |
| Hepatitis C virus/Hepatit C virüsü.....................................25, 62 |
| Hepatitis C virus/Hepatitis C virus..........................................55 |
| Hepatitis C/Hepatit C.......................................................19, 105 |
| Hepatitis C/Hepatitis C............................................................32 |
| Hepatitis delta virus/Hepatit delta virüs..................................14 |
| Hepatitis/Hepatit.................................................75, 79, 84, 113 |
| Hepatocellular carcinoma and cirrhosis/Hepatosellüler karsinom ve siroz...113 |
| Hepatocellular carcinoma/Karaciğer kanseri...........................32 |
| HIV/HIV....................................................................................75 |
| Hospital/Hastane.......................................................................6 |
| Immunosuppressive therapy/İmmünosupresif tedavi...........50 |
| Intravenous drug use/Damar içi madde kullanımı.................55 |
| Knowledge/Bilgi.........................................................................6 |
| Liver biopsy/Karaciğer Biyopsisi.............................................45 |
| Liver/Karaciğer...........................................................................1 |
| Migration/Göç..........................................................................62 |
| miRNA/miRNA......................................................................113 |
| Mixed genotype HCV/Miks genotip.......................................55 |
| Molecular microbiology/Moleküler mikrobiyoloji....................62 |
| Naive/Naiv................................................................................19 |
| Necroinflammation/Nekroinflamasyon...................................67 |
| Needle/İğne...............................................................................1 |
| Non-Hodgking B cell lymphoma/ |
| Non-Hodking B cell lenfoma...................................................32 |
| Nucleos(t)ide analogue/Nucleos(t)ide analoğu.......................40 |
| Occult hepatitis B/Okült hepatit B..........................................88 |
| Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir/Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir.109 |
| Prevalence/Prevalans.............................................................101 |
| Prognosis/Prognoz...................................................................19 |
| Prophylaxis/Profilaksi...............................................................50 |
| Retrobulbar blood flow velocity/Retrobulbar kan akımı.........35 |
| Risk group/Risk grubu.............................................................79 |
| ROC analysis/ROC analizi........................................................97 |
| Seropositivity/Seropozitiflik.....................................................75 |
| Seroprevalence/Seroprevalans................................................79 |
| Sexual dysfunction/Cinsel disfonksiyon.................................25 |
| Syria/Suriye..............................................................................84 |
| Technique/Teknik.......................................................................1 |
| Virus/Virüs................................................................................84 |